Position in LH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,303,380
+$237,363 QoQ
Shares Held
19,877
-1.6% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026US BANCORP \DE\ holds $252,886,550 across 31 Diagnostics & Research names. LH ranks #6 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
598,192 | $113,417,201 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
166,108 | $81,647,064 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
15,200 | $8,540,726 | |
| 4 | A |
Agilent Technologies, Inc.
|
53,749 | $6,126,309 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
31,459 | $5,365,016 | |
| 6 | LH |
Labcorp Holdings Inc.
This page
|
19,877 | $5,303,380 | |
| 7 | ILMN |
Illumina, Inc.
|
35,531 | $4,379,550 | |
| 8 | DGX |
Quest Diagnostics Inc
|
20,905 | $4,096,960 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,303,380 | 19,877 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,066,017 | 20,193 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $6,100,310 | 21,251 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $5,664,176 | 21,577 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $5,094,443 | 21,889 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $5,141,581 | 22,421 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $4,984,273 | 22,303 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $4,878,946 | 23,974 | Shares | Defined | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||